Browse
Submit Data
Databases
API
Help

Dataset Information

6 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Flare Type Self-expandable Metal Stent for Malignant Colorectal Obstruction

ABSTRACT: This study compares flare type self-expandable metal stent with conventional D-type self-expandable metal stent for malignant colorectal obstruction.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2278863 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Self-expandable Metal Stent (SEMS) Endoscopic Placement for Malignant Colonic Obstruction Therapy

Project description:Compare the effectiveness of Self-expandable metal stent (SEMS) and diverting stoma formation for the bowel preparation as a bridge to surgical treatment of patients with MCO.

| 1874 | ecrin-mdr-crc

Comparison of Efficacy Between a Newly Designed Covered Stent and Uncovered Stent for Malignant Colorectal Obstruction

Project description:Acute colorectal obstruction has been reported to occur in 7 - 29% of all colorectal malignancies, but emergent surgical decompression is associated with high morbidity and mortality rates. Recently, self-expandable metal stents(SEMS) have been suggested as an alternative to surgery and effectively decompress the colonic obstruction and allow for bowel preparation and elective surgery. Theoretically, SEMSs are classified into uncovered stents and covered stents. Covered stents have the advantage of less frequent stent occlusion by tumor in-growth and the disadvantage of a high risk of stent migration, whereas uncovered stents are associated with less stent migration, although they appear to be more prone to tumor ingrowth. To overcome the drawbacks of conventional stents, a double-layered combination covered stent was developed. In the present study, the investigators evaluated the efficacy and safety of the newly designed covered stent by comparing it with the uncovered stent in patients with malignant colorectal obstruction.

| 2205076 | ecrin-mdr-crc

Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction

Project description:RATIONALE: The use of endoscopy to place a metal stent in the large intestine is less invasive than surgery for treating cancer-related bowel obstruction and may have fewer side effects and improve recovery. PURPOSE: Phase I/II trial to study the effectiveness of endoscopic placement of a metal stent in treating patients who have cancer-related bowel obstruction.

| 2004056 | ecrin-mdr-crc

Effect on CTC about the self-expandable stent on acute obstruction of left colorectal cancer and rectal cancer

Project description:Interventions: BTS group:first, Self-expanding metallic stent (SEMS) insertion, then, elective surgery;emergency surgery group:emergency surgery for obstruction caused by left sided colorectal cancer Primary outcome(s): Circulating tumour cells Study Design: Non randomized control

| 2670453 | ecrin-mdr-crc

Real-time quantitative PCR analysis of rat aorta samples after stent deployment

Project description:Bare Metal Stents (BMS), Drug Eluting Stent (DES) and Exosomes Eluting Stent (EES) were placed in rat abdominal aorta for one week. Then total RNA of aortas was extracted. We used ScienCell's GeneQuery Rat Macrophage Polarization Markers qPCR Array Kit to quantitate gene expression of macrophage relevant genes.

2021-04-30 | GSE155793 | GEO

Long-term Outcomes of Colonic Stent as a "Bridge to Surgery" for Malignant Large-bowel Obstruction

Project description:Study of long-term outcomes of colonic stent as a "bridge to surgery" for malignant large-bowel obstruction.

| 2317928 | ecrin-mdr-crc

Inflammation and Extracellular Matrix Genes Differentially Expressed Following Overlapping Zotarolimus- and Sirolimus-Eluting Stent Implantation

2011-04-22 | GSE28781 | GEO

Inflammation and Extracellular Matrix Genes Differentially Expressed Following Overlapping Zotarolimus- and Sirolimus-Eluting Stent Implantation

Project description:An unanticipated complication of the use of bare metal stents in percutaneous transluminal coronary angioplasty is in-stent restenosis resulting in >50% late lumen diameter loss in treated patients. In an effort to reduce in-stent restenosis, drug eluting stents containing the immunosuppressant sirolimus or zotarolimus have recently been developed. We report here the molecular response of arterial tissue to the implanting of these drug-eluting stents. Gene expression profiling was performed on 4 artery segments surrounding bare metal stents (BMS), 4 artery segments surrounding sirolimus-eluting stents (SES), and 4 artery segments surrounding zotarolimus-eluting stents (ZES) implanted into porcine animal models for 28 days.

2011-04-22 | E-GEOD-28781 | biostudies-arrayexpress

Randomized controlled trial of stent placement in patients with inoperable malignant colorectal obstruction (JIVROSG-0806)

Project description:Interventions: Stent placement in the region of colonic stenosis. Other treatments except surgical intervention. Primary outcome(s): Improvement of the symptoms from colorectal obstruction. Study Design: Parallel Randomized

| 2619030 | ecrin-mdr-crc